Stocks and Investing
Stocks and Investing
Tue, September 14, 2021
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
[ Tue, Sep 14th 2021
] - WOPRAI
Mon, September 13, 2021
[ Mon, Sep 13th 2021
] - WOPRAI
[ Mon, Sep 13th 2021
] - WOPRAI
[ Mon, Sep 13th 2021
] - WOPRAI
[ Mon, Sep 13th 2021
] - WOPRAI
[ Mon, Sep 13th 2021
] - WOPRAI
[ Mon, Sep 13th 2021
] - WOPRAI
[ Mon, Sep 13th 2021
] - WOPRAI
[ Mon, Sep 13th 2021
] - WOPRAI
[ Mon, Sep 13th 2021
] - WOPRAI
[ Mon, Sep 13th 2021
] - WOPRAI
[ Mon, Sep 13th 2021
] - WOPRAI
[ Mon, Sep 13th 2021
] - WOPRAI
[ Mon, Sep 13th 2021
] - WOPRAI
Yale Jen Initiated (VINC) at Strong Buy and Held Target at $30 on, Sep 13th, 2021
Yale Jen of Laidlaw & Co., Initiated "Vincerx Pharma, Inc." (VINC) at Strong Buy and Held Target at $30 on, Sep 13th, 2021.
Yale has made no other calls on VINC in the last 4 months.
There are 2 other peers that have a rating on VINC. Out of the 2 peers that are also analyzing VINC, 0 agree with Yale's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Yale
- Kalpit Patel of "B. Riley Securities" Initiated at Strong Buy and Held Target at $26 on, Wednesday, August 25th, 2021
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $30 on, Friday, August 13th, 2021
Contributing Sources